Evidence map›Paper›PMID 29248611›Full record

ReviewExperimental hematology2018

A vicious interplay between genetic and environmental insults in the etiology of blood cancers.

Anna Rita Migliaccio

Abstract readReview
In one paragraph

Review in Experimental hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. The Role of Inflammation in CMML Pathobiology and Progression.Current hematologic malignancy reports · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Anna Rita MigliaccioDepartment of Biomedical and Neuromotorial Sciences, Alma Mater University, Bologna, Italy; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York. Electronic address: annarita.migliaccio@mssm.edu.
University of Bologna · IT

Funding

Tissue BankP01CA108671 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ronald Hoffman · 2006 to 2026
$82.0M
STUDIES ON THE DUFFY BLOOD GROUP (FY) ANTIGENP50HL054459 · NHLBI · NEW YORK BLOOD CENTER · PI HALVERSON, GREGORY RAY · 1996 to 2005
$8.6M
The human glucocorticoid receptor and normal and pathological terminal erythroidR01HL116329 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MIGLIACCIO, ANNA RITA F · 2012 to 2015
$1.7M
NCI NIH HHS P01 CA108671NHLBI NIH HHS P50 HL054459NHLBI NIH HHS R01 HL116329
6 · The paper itself

Abstract

Over the years, the etiology of cancer has been attributed alternatively to genetic and environmental insults. According to the genetic hypothesis, cancer cells arise from the acquisition of mutations that dysregulate the intrinsic mechanisms controlling normal cell growth and survival. In contrast, the environmental hypothesis holds that cancer can be caused by multiple extrinsic challenges that alter normal tissue homeostasis, but may not necessarily involve mutations. It is, however, quite possible that these two mechanisms are not mutually exclusive. According to this third hypothesis, environmental challenges, by mechanisms still poorly understood, may act by imposing a selection pressure that confers a proliferative advantage on cells carrying specific driver mutations, leading to disease initiation. The authors of a brief report published in this journal (Exp Hematol. 2017;56:1-6) tested this third hypothesis experimentally and provide new evidence that chronic inflammation, by increasing tumor necrosis factor (TNF)-α, may positively select malignant hematopoietic stem cells (HSCs) carrying loss-of-function TET2 mutations that switch the TNF-α signaling responses to activate proliferation rather than inducing quiescence. Furthermore, these mutations skew hematopoietic differentiation toward the myelomonocytic lineage and the output of macrophages producing TNF-α constitutively, promoting further environment-independent expansion of the malignant HSCs. These findings support a model in which the formation of a malignant population is triggered by a vicious interplay between genetic (TET2 mutations) and environmental (inflammation) insults, suggesting the need for strategies that target both the malignant cells and their environment.

Indexed as

Cell DifferentiationGene-Environment InteractionHematopoiesisHematopoietic Stem CellsMutationNeoplastic Stem CellsAnimalsDioxygenasesDNA-Binding ProteinsHematologic NeoplasmsHumansProto-Oncogene ProteinsStem Cell NicheTumor MicroenvironmentTumor Necrosis Factor-alphaDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsTET2 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID29248611
PMCPMC6381597
OpenAlexW2771723656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.